CP, today's rise is likely to be linked to a large article in the FT page 3. Titled 'Random tests put spotlight on abuse' in talks of the growing use of drug tests in the workplace. As far as i can remember Wyatt isn't mentioned, although concento figures prominently.
Spoke to of mergers etc in the sector. Concento bought Medscreen for £30m. Medscreen had turnover of just £2.4m.............
At the interims a few days ago:
Keith Tozzi, Chairman, Concateno plc said:
"It has been a period of change and progress for Concateno. In Medscreen, we
have acquired a fantastic platform for growth in this fast growing, yet highly
fragmented life science testing sector. Concateno will continue to play a role
in the consolidation of this market.